---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-004111"
form_type: "8-K"
ticker: "MCRB"
cik: "0001609809"
company_name: "Seres Therapeutics, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:52:35.340771+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Seres Therapeutics posts corporate presentation at J.P. Morgan Conference; content not fully available

## Summary
- Filed updated corporate presentation as Exhibit 99.1 on January 9, 2023.
- Presentation dated January 2023 for 41st Annual J.P. Morgan Healthcare Conference.
- CEO Eric Shaff featured; specific pipeline or financial details not included in excerpt.
- No new material information can be confirmed from the limited exhibit text provided.

## SEC filing metadata
- accession: 0001193125-23-004111
- form_type: 8-K
- ticker: MCRB
- cik: 0001609809
- company_name: Seres Therapeutics, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609809/000119312523004111/0001193125-23-004111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609809/000119312523004111/d439121d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-004111
- JSON: https://secwatch.observer/filing/0001193125-23-004111.json
- Plain text: https://secwatch.observer/filing/0001193125-23-004111.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.